Abion Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abion Inc with three other
miscellaneous service companies in Asia:
Pharmacore Biotech Co Ltd
sales of 41.53 million Taiwanese Dollars [US$1.49 million]
JHBP CY Holdings Ltd
of HONG KONG
(11.64 million Hong Kong Dollars [US$1.50 million]
of which 100%
was Research and development of biopharmaceu), and
based in JAPAN
(199.47 million Japanese Yen [US$1.81 million]
of which 74%
was Regenerative Medicine Business Support).
During the year ended December of 2020, sales at
Abion Inc were 1.99 billion Korean Won (US$1.76 million).
increase of 62.1%
versus 2019, when the company's sales were 1.23 billion Korean Won .